ÃâÒßѧÊÔÌâ
sb8%!>C Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
#G</RYM~m 1. Fas(CD95)/FasL
R _#x 2. common chain of cytokine receptor
ug?gVK 3 . TCR/CD3 complex
JmMB=}
< 4. negaive selection of thymocytes
t:MeSO 5. artificial active immune
jb0wP01R 6. anti-idiotypic
N, `q1B 7. IgSF
JONfNb+ 8. Integrin
h%4aL38 9. chemokine
UA>
3,|gV1 10. B7/CD28
Y-Iu&H+\ ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
|nOqy&B 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
p\;\hHai 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
y!z2+q2 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
[{!K'V 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
}~I(e
#%Hk-a=>)# 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
I{bDa'rX µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
`efC4#*!! Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
ON(OYXj 1. B7/CD28
ye<b`bL2. 2. Th1 subset
1iA0+Ex(j 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
)2z<5 ` 4. antibody affinity maturation
_h6j, ) 5. AP-1
A&?8 rc
6. single chain variable fragment£¨ScFv£©
/"+CH\)
E 7. NK cell receptor
]!c59%f= 8. Zinkernagel-Doherty phenomenon
-1_WE/Ps 9. Ig fold
Wtwo1pp 10. CD40/CD40L
8AjQPDn+ ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
u1}/SlCp 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
"|Ke/0rGB 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
}s7@0#j@a 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
@Ojbu@A Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
z|F38(%JJN 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
uGmv`R_ 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
7z2Q!0Sz 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
k/Z]zZC Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
I[6ft_* £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
=Lh8#>T\h Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
e**<et. 1.Co-stimulators (or co-stimulating molecules)
\y(ZeNs 2.NK-kB
aMJW__, 3.Immunoglobulin superfamily
XtZeT~/7RT 4.antigen-presenting cell (APC)
R?3N><oh* 5.death domain
Z=m5V (9 6.CCR and CXCR
[t6Y,yo&h4 7.Lectin (or mitogen)
[Ot<8)Jm 8.Clusters of differentiation, CD)
`t>A~.f 9.B7 family
>1qum' 10.Cytotoxic T lymphocyte, CTL)
HEk{!Y 11.IL-15 and IL-15 receptor (IL-15R)
}Ip1|Gj 12.MHC restriction
cGSG}m@B` 13.Affinity-chromatography
aKFY&zN? 14.Cyctosprin A, CsA
JLbmh1' 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
|})v,
oB ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
?orLc,pU^ 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
;d.gVR_V 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
[#SiwhF| 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
)zydD=,bu Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
`)tIXMn ÃâÒßѧרҵ£º
d3]<'B:nb 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
Ov#G 7a" Ïû»¯ÄÚ¿Æ£º
)&$mFwf 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
Eq=j+ch7 ѪҺ²¡Ñ§×¨Òµ£º
GP(ze-Y
p 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
vawS5b
; Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
Os/?iGlD*E (רҵ»ù´¡: ÃâÒßѧ)
XFv^jSF Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
qi['~(( 1. ADCC(antibody dependent cell-mediated cytotoxicity)
;YZ'd"0v 2. »·æß¾úËØ(cyclosporin)
&
h\!#X0 3. KIR(killer cell inhibitory receptor)
(e#f 4. HLDA(human leucocyte differentiation antigen)
cEIs9; 5. Interleukin 18(IL-18)
TSH'OW !b 6. ÕûºÏËØ(integrin)
A`* l+M^z 7. Fas/FasL
T0@$6&b%\z 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
h!7Lvh`o 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
9TZ
6c 10. Th1/Th2
Y[s}?Xu]w# 11. »ùÒòÒßÃç(DNAÒßÃç)
AYAbq}'Yt 12. chemokines and chemokine receptor
1/v#Z#3[ 13. ÃâÒßÄÍÊÜ
r)Ja\; 14. ¹²´Ì¼¤·Ö×Ó
]QQeUxi 15. ËÀÍö½á¹¹Óò(death domain)
+ (Jh$b_ ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
%Iiu#- 'B 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
LKA/s ~G 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
wlEK"kKU £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
Os*s{2OvO £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
@SI,V8i £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
Fd<eh(g9P £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
[{:
l
? 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
Ed+jSO0 Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
_
}cD_$D ÎÊ´ðÌâ(ÿÌâ25·Ö)
TiR00#b 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
r^{Bw1+ 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
i.^:xZ 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
5?0~7^de 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£